Statin therapy in critical illness: an international survey of intensive care physicians’ opinions, attitudes and practice

Table 2 Preferred follow up duration for the proposed statin interventional trial

follow up duration	overall - %	uk - %	anz - %	p*
1-7 days	1.9	1.4	3.2	0.585
8-14 days	3.4	4.1	1.6	0.677
15-21 days	2.4	2.8	1.6	1.000
21-28 days	33.3	37.9	22.6	0.032
3 months	29.0	22.8	43.6	0.003
6 months	26.1	28.3	21.0	0.304
other	3.9	2.8	6.5	0.244
total	100	100	100

Shows respondents’ preferred follow up duration for the proposed statin interventional trial. Data are presented as proportions. ^* p value for comparison of United Kingdom versus Australia and p = 0.024 when comparing the overall frequency distribution of the responses for ANZ and UK.